Analysis of the association of influenza clinical course with single nucleotide polymorphisms in genes affecting the interferon-λ3 production
- Authors: Nikolaeva L.I.1, Stuchinskaya M.D.1, Telepenina K.P.1, Shevchenko N.G.1, Kuprianov V.V.1, Krasnoslobodtsev K.G.1, Mukasheva E.A.1, Trushakova S.V.1, Khlopova I.N.1, Kruzhkova I.S.1, Kisteneva L.B.1, Kolobukhina L.V.1, Burtseva E.I.1
-
Affiliations:
- N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
- Issue: Vol 70, No 1 (2025)
- Pages: 25-34
- Section: ORIGINAL RESEARCH
- URL: https://journal-vniispk.ru/0507-4088/article/view/287907
- DOI: https://doi.org/10.36233/0507-4088-271
- EDN: https://elibrary.ru/hnrscv
- ID: 287907
Cite item
Abstract
Introduction. Predisposition to different courses of the infectious process is largely associated with the polymorphisms in human genome, especially in genes encoding proteins of the immune system. In the early stages of influenza infection such components of innate immunity as interferons I (α/β) and III (λ) type play a significant role in limiting virus replication.
The aim of the work was to investigate associations of single nucleotide polymorphism in IFNL3 (rs8099917 T/G) and IFNL4 (rs12979860 C/T) genes with different course of influenza, and identify genetic markers of influenza complicated by community-acquired pneumonia. The genes noted above affect the production of interferon-λ3, which is involved in restriction of the viral replication.
Materials and methods. Samples from 456 patients with mild (n = 150), moderate (n = 173), and severe (n = 133) influenza were studied. The viral RNA was detected by reverse transcription and polymerase chain reaction (RT-PCR). Polymorphisms in IFNL3 (rs8099917 T/G) and IFNL4 (rs12979860 C/T) genes was detected by PCR. Statistical analysis was performed using SNPStats software.
Results. Patients with the C/T or T/T genotype of IFNL4 gene (rs12979860 C/T) were more likely to have pneumonia than those with the C/C genotype (OR 2.47 (1.31–4.63); p = 0.0044; q = 0.0059). The presence of one T allele increased the risk of developing pneumonia (OR 2.02 (1.05–4.02); p = 0.006; q = 0.008). In the presence of the T/T genotype, the risk increased more than twofold: OR 2.14 (1.31–3.48). Analysis of the SNP of IFNL3 gene (rs8099917 T/G) revealed a weak association of the G allele with pneumonia (OR 1.86 (1.04–3.31); p = 0.03; q = 0.045).
Conclusion. Genetic markers of increased risk of community-acquired pneumonia in influenza include the presence of the T allele in IFNL4 gene (rs12979860 C/T) and, to a lesser extent, the G allele in IFNL3 gene (rs8099917 T/G). Patients carrying these alleles have an increased risk of developing pneumonia, especially in old age.
Full Text
##article.viewOnOriginalSite##About the authors
Lyudmila I. Nikolaeva
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Author for correspondence.
Email: l.i.nikolaeva@mail.ru
ORCID iD: 0000-0002-1323-5568
D. Sci. in Biol., Leading Researcher of the Laboratory of Gene Engineering Products
Russian Federation, 123098, MoscowMaya D. Stuchinskaya
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: mayastay@mail.ru
ORCID iD: 0000-0001-8544-7482
Junior Researcher of the Laboratory of Gene Engineering Products
Russian Federation, 123098, MoscowKristina P. Telepenina
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: telepenina_kristina@mail.ru
ORCID iD: 0009-0003-3380-5104
Researcher Assistant of the Laboratory of Gene Engineering Products
Russian Federation, 123098, MoscowNadezhda G. Shevchenko
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: dr.nadya@inbox.ru
ORCID iD: 0000-0002-2486-4554
Junior Researcher of the Laboratory of Gene Engineering Products
Russian Federation, 123098, MoscowVictor V. Kuprianov
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: vkoop@mail.ru
ORCID iD: 0000-0002-8602-1974
C. Sci. in Biol., Senior Researcher of the Laboratory of Gene Engineering Products
Russian Federation, 123098, MoscowKirill G. Krasnoslobodtsev
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: kkg_87@mail.ru
ORCID iD: 0000-0003-1745-9128
Researcher of the Laboratory of Influenza Etiology and Epidemiology
Russian Federation, 123098, MoscowEvgenya A. Mukasheva
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: mukasheva_evgeniya@mail.ru
ORCID iD: 0000-0002-5688-5309
Researcher of the Laboratory of Influenza Etiology and Epidemiology
Russian Federation, 123098, MoscowSvetlana V. Trushakova
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: s.trushakova@gmail.com
ORCID iD: 0000-0002-9610-3041
C. Sci. in Biol., Senior Researcher of the Laboratory Influenza Etiology and Epidemiology
Russian Federation, 123098, MoscowIrina N. Khlopova
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: khlopova.ira@yandex.ru
ORCID iD: 0000-0002-7419-590X
C. Sci. in Med., Leading Researcher of the Laboratory of Chronic Viral Infections
Russian Federation, 123098 MoscowIrina S. Kruzhkova
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: irina-kru@yandex.ru
ORCID iD: 0000-0002-1983-481X
Researcher of the Laboratory of Respiratory Viral Infection with Drug Testing
Russian Federation, 123098, MoscowLidya B. Kisteneva
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: lborisovna2007@yandex.ru
ORCID iD: 0000-0001-7336-409X
D. Sci. in Med., Leading Researcher of the Laboratory of Chronic Viral Infections
Russian Federation, 123098, MoscowLyudmila V. Kolobukhina
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: lkolobuchina@yandex.ru
ORCID iD: 0000-0001-5775-3343
D. Sci. in Med., Chief Researcher of Respiratory Viral Infection with Drug Testing
Russian Federation, 123098, MoscowElena I. Burtseva
N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia
Email: elena-burtseva@yandex.ru
ORCID iD: 0000-0003-2518-6801
D. Sci. in Med., Leading Researcher of the Influenza Etiology and Epidemiology
Russian Federation, 123098, MoscowReferences
- Iuliano A.D., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018; 391(10127): 1285–300. https://doi.org/10.1016/s0140-6736(17)33293-2
- Аcute respiratory viral diseases in adults: Clinical recommendations. National Infectious Diseases Scientific Society, 2014. Available at: https://library.mededtech.ru/rest/documents/ORVI_adult/ (in Russian)
- Isakov V.A. Clinical and pathogenetic aspects of severe influenza. Allergologiya i immunologiya. 2002; 3(1): 136–44. https://elibrary.ru/xvrzmd (in Russian)
- Pokrovskii V.I., Semenov B.F. The concept of delayed death in influenza and vaccine prevention tactics for heart attacks, strokes and deaths from this infection. Rossiiskii meditsinskii zhurnal. 2003; 11(22): 1266–72. https://elibrary.ru/weoptp (in Russian)
- Shi J., Zeng X., Cui P., Yan C., Chen H. Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg. Microbes Infect. 2023; 12(1): 2155072. https://doi.org/10.1080/22221751.2022.2155072
- de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006; 12(10): 1203–7. https://doi.org/10.1038/nm1477
- Nikolaeva L.I., Sapronov G.V., Kupriyanov V.V. The role of the interferons-lambda in immune protection against influenza. Infektsionnye bolezni. 2019; 17(1): 86–92. https://doi.org/10.20953/1729-9225-2019-1-86-92 https://elibrary.ru/dcfhfp (in Russian)
- Klinkhammer J., Schnepf D., Ye L., Schwaderlapp M., Gad H.H., Hartmann R., et al. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife. 2018; 7: e33354. https://doi.org/10.7554/elife.33354
- Fox J.M., Crabtree J.M., Sage L.K., Tompkins S.M., Tripp R.A. Interferon lambda upregulates IDO1 expression in respiratory epithelial cells after influenza virus infection. J. Interferon Cytokine Res. 2015; 35(7): 554–62. https://doi.org/10.1089/jir.2014.0052
- Davidson S., McCabe T.M., Crotta S., Gad H.H., Hessel E.M., Beinke S., et al. IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment. EMBO Mol. Med. 2016; 8(9): 1099–112. https://doi.org/10.15252/emmm.201606413
- Kim S., Kim M.J., Kim C.H., Kang J.W., Shin H.K., Kim D.Y., et al. The superiority of IFN-λ as a therapeutic candidate to control acute influenza viral lung infection. Am. J. Respir. Cell Mol. Biol. 2017; 56(2): 202–12. https://doi.org/10.1165/rcmb.2016-0174oc
- Feld J.J., Kandel C., Biondi M.J., Kozak R.A., Zahoor M.A., Lemieux C., et al. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir. Med. 2021; 9(5): 498–510. https://doi.org/10.1016/s2213-2600(20)30566-x
- Lazear H.M., Nice T.J., Diamond M.S. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity. 2015; 43(1): 15–28. https://doi.org/10.1016/j.immuni.2015.07.001
- Otdel’nova K.A. Determination of the required number of observations in complex social and hygienic studies. In: Proceedings of N.I. Pirogov Medical Institute «Complex socio-hygienic studies and clinical and social research» [Sbornik trudov meditsinskogo instituta im. N.I. Pirogova «Kompleksnye sotsial’no-gigienicheskie issledovaniya i kliniko-sotsial’nye issledovaniya»]. Moscow; 1980. (in Russian)
- L’vov D.K., Burtseva E.I., Kolobukhina L.V., Fedyakina I.T., Kirillova E.S., Trushakova S.V., et al. Virological, epidemiological, clinic, and molecular genetic features of the influenza epidemic in 2015-2016: prevailing of the influenza A(H1N1)09 pdm virus in Russia and countries of the Northern hemisphere. Voprosy virusologii. 2016; 61(4): 159–65. https://doi.org/10.18821/0507-4088-2016-61-4-159-166 (in Russian)
- Kurdin A., Ambalov Yu., Pshenichnaya N. The importance of polymorphisms of lambda-interferon genes in pathogenesis and clinical aspects of Flua and other acute respiratory-viral infections. Glavnyi vrach Yuga Rossii. 2017; (3): 49–50. https://elibrary.ru/yzbirt (in Russian)
- Keshavarz M., Namdari H., Farahmand M., Mehrbod P., Mokhtari-Azad T., Rezaei F. Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population. Virol. J. 2019; 16(1): 79. https://doi.org/10.1186/s12985-019-1187-8
- Parakhonskii A.P. Aging of the immune system. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii. 2011; (6-1): 73–4. https://elibrary.ru/necmtj (in Russian)
Supplementary files
